跳至主要内容
临床试验/NCT03553758
NCT03553758已完成2 期

Electroencephalogram Studies of Induction and Recovery From Ketamine-Induced General Anesthesia

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2018年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
16
试验地点
1
主要终点
Average Pain Intensity Pre- and Post-Ketamine Induction

研究概览

简要总结

We are doing this research study to find out how and where ketamine acts in the brain. Ketamine is an anesthetic (a drug or agent used to decrease or eliminate the feeling of pain by putting you in an unconscious state). We will look at the brain using a machine that records the brain's electrical activity, called an electroencephalogram (EEG). We will assess how it impacts patient's pain responses.

详细描述

In this trial, participants will be given ketamine at a high enough dosage to induce general anesthesia. EEG recording will be conducted during this time. Cognitive assessments and pain monitoring will be administered at various points before and after ketamine induction.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Between the ages of 18 to 45
  • Normal body weight and habitus, BMI less than or equal to 30
  • Non-smoker
  • American Society of Anesthesiologists (ASA) physical status classification P1

排除标准

  • Cardiovascular: myocardial infarction, coronary artery disease, peripheral vascular disease, arrhythmia, congestive heart failure, valvular disease, hypertension
  • Respiratory: bronchitis, chronic obstructive pulmonary disease, smoking, shortness of breath
  • Hepatic: hepatitis, jaundice, ascites
  • Neurologic: seizure, stroke, positive neurologic findings on neurologic examination, multiple sclerosis, Meniere's disease, Parkinson's disease, neuropathy, peripheral stenosis
  • Gastrointestinal: esophageal reflux, hiatal hernia, ulcer
  • Endocrine: diabetes, thyroid disease
  • Renal: acute or chronic severe renal insufficiency
  • Hematologic: blood dyscrasias, anemia, coagulopathies, on anticoagulant therapy
  • Musculoskeletal: prior surgery or trauma to head neck or face, arthritis, personal or family history of malignant hyperthermia
  • Psychiatric: history or treatment for an active psychiatric problem, depression
  • Reproductive: pregnancy, breast-feeding
  • Medications: regular use of prescription and non-prescription medications expected to affect CNS function, St. John's Wort
  • Allergies: labetalol, ondansetron, glycopyrrolate, ketamine, midazolam

研究组 & 干预措施

Ketamine

Experimental

15 subjects undergoing ketamine general anesthesia.

干预措施: Ketamine (Drug)

结局指标

主要结局

Average Pain Intensity Pre- and Post-Ketamine Induction

时间窗: Approximately 125 minutes

Average Pain Intensity prior to ketamine induction, 30 minutes post ketamine, 60 minutes post ketamine, 75 minutes post ketamine, and 120 minutes post ketamine. PROMIS Pain Intensity 1a was used to assess pain delivered by a pre-calibrated pain cuff. Scale of 0 (no pain) to 10 (worst imaginable pain).

次要结局

  • Average Dissociation States Score Pre- and Post-Ketamine Induction(About 125 minutes)
  • Difference of the Mean Clinician Administered Dissociative States Scale Before and After Midazolam Administration(About 60 minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Oluwaseun Johnson-Akeju, MD, MMSc

Associate Professor of Anaesthesia

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验